Background/Aim: Some studies have identified an association of kidney stone formation with vitamin D receptor (VDR) or calcium-sensing receptor (CaSR) polymorphisms. We aimed to evaluate the association between these polymorphisms with urinary calcium excretion (uCa) in calcium- stone-forming patients. Methods: VDR polymorphism, detected by BsmI digestion, and 3 CaSR polymorphisms (G/T at codon 986, G/A at codon 990 and C/G at codon 1011), detected by direct sequencing, were evaluated in 100 hypercalciuric (HCa) and 101 normocalciuric (NCa) calcium-stone-forming patients. Results: The total allelic frequency of VDR polymorphism was: 16% BB, 49% Bb and 35% bb. The prevalence of bb genotype was significantly higher in the HCa when compared to the NCa group (43 vs. 27%). With respect to CaSR polymorphisms, 986S, 990G and 1011E variant alleles were detected, respectively, in 5, 4 and 3% of the whole sample and 5 CaSR haplotypes were identified: 94% ARQ (wild-type), 3% SRQ, 1.5% AGQ, 1.0% ARE and 0.5% AGE. No statistical differences have been observed between NCa and HCa with respect to these CaSR haplotypes. Conclusions: The present study suggested that bb homozygous for VDR polymorphism was overrepresented in hypercalciuric stone formers. Urinary calcium excretion was not associated with CaSR polymorphism in the present sample.

Keywords:
Bone mineral density, Calcium-sensing receptor, Idiopathic hypercalciuria, Nephrolithiasis, Vitamin D receptor
1.
Moe OW: Kidney stones: Pathophysiology and medical management. Lancet 2006;367:333–344.
2.
Coe FL, Evan A, Worcester E: Kidney stone disease. J Clin Invest 2005;115:2598–2608.
3.
Levy FL, Adams-Huet B, Pak CY: Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995;98:50–59.
4.
Heilberg IP: Hypercalciuria; in Martini L (ed): Encyclopedia of Endocrine Diseases San Diego, Academic Press, 2004, vol 2, pp 530–536.
5.
Bushinsky DA, Frick KK, Nehrke K: Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 2006;15:403–418.
6.
Gomes SA, dos Reis LM, Noronha IL, Jorgetti V, Heilberg IP: RANKL is a mediator of bone resorption in idiopathic hypercalciuria. Clin J Am Soc Nephrol 2008;3:1446–1452.
7.
Moe OW, Bonny O: Genetic hypercalciuria. J Am Soc Nephrol 2005;16:729–745.
8.
Favus MJ, Karnauskas AJ, Parks JH, Coe FL: Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 2004;89:4937–4943.
9.
Karnauskas AJ, van Leeuwen JP, van den Bemde GJ, Kathpalia PP, DeLuca HF, Bushinskyi DA, Favus MJ: Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Mineral Res 2005;20:447–454.
10.
Scott P, Oimet D, Valiquette L, Guay G, Proulx Y, Trouvé ML, Gagnon B, Bonnardeaux A: Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J Am Soc Nephrol 1999;10:1007–1013.
11.
Vezzoli G, Soldati L, Gambaro G: Update on primary hypercalciuria from a genetic perspective. J Urol 2008;179:1676–1682.
12.
Morrisson NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284–287.
13.
Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B: The Bsm I vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res 1995;10:985–990.
14.
Lazaretti-Castro M, Duarte-de-Oliveira MA, Russo EMK, Vieira JGH: Vitamin D receptor alleles and bone mineral density in a normal premenopausal Brazilian female population. Br J Med Biol Res 1997;30:929–932.
15.
Zambrano-Morales M, Borjas L, Fernández E, Zabala W, de Romero P, Pineda L, Morales-Machín A: Association of vitamin D receptor gene BBAAtt haplotypes with osteoporosis in post-menopausic women. Invest Clin 2008;49:29–38.
16.
Heilberg IP, Teixeira SH, Martini LA, Boim MA: Vitamin D receptor gene polymorphism and bone mineral density in hypercalciuric calcium-stone-former patients. Nephron 2002;90:51–57.
17.
Uitterlinden AG, Raslton SH, Brandi ML, Carey AH, Grinberg D, Langdahl BL, Lips P, Lorenc R, Obermayer-Pietsch B, Reeve J, Reid DM, Amedei A, Bassiti A, Bustamante M, Husted LB, Diez-Perez A, Dobnig H, Dunning AM, Enjuanes A, Fahrleitner-Pammer A, Fang Y, Karczmarewicz E, Kruk M, van Leeuwen JP, Mavilia C, van Meurs JB, Mangion J, McGuigan FE, Pols HA, Renner W, Rivadeneira F, van Schoor NM, Scollen S, Sherlock RE, Ioannidis JP: The association between common vitamin D receptor gene variations and osteoporosis: participant-level meta-analyses. Ann Intern Med 2006;145:255–264.
18.
McDonald HM, McGuigan FE, Stewart A, Black AJ, Fraser WD, Ralston S, Reid DM: Large-scale population-based study shows no evidence of association between common polymorphism of the VDR gene and BMD in British women. J Bone Miner Res 2006;21:151–162.
19.
Charopoulos I, Trovas G, Stathopoulou M, Kyriazopoulos P, Galanos A, Dedoussis G, Antonogiannakis E, Lyritis GP: Lack of association between vitamin D and calcitonin receptor gene polymorphisms and forearm bone values of young Greek males. J Musculoskelet Neuronal Interact 2008;8:196–203.
20.
Zerwekh JE, Hughes MR, Reed BY, Breslau NA, Heller HJ, Lemke M, Nasonkin I, Pak CYC: Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria. J Clin Endocrinol Metab 1995;80:2960–2965.
21.
Ruggiero M, Pacini S, Amato M, Aterini S, Chiarugi V: Association between vitamin D receptor gene polymorphism and nephrolithiasis. Miner Electrolyte Metab 1999;25:185–190.
22.
Vezzoli G, Soldati L, Proverbio MC, Adamo D, Rubinacci A, Bianchi G, Mora S: Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones. J Nephrol 2002;15:158–164.
23.
Mossetti G, Vuotto P, Rendina D, Numis FG, Viceconti R, Giordano F, Cioffi M, Scopacasa F, Nunziata V: Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis. J Intern Med 2003;253:194–200.
24.
Rendina D, Mossetti G, Viceconti R, Sorrentino M, Castaldo R, Manno G, Guadagno V, Strazzullo P, Nunziata V: Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients. Urology 2004;64:833–838.
25.
Soylemezoglu O, Ozkaya O, Gonen S, Misirhoglu M, Kalman S, Buyan N: Vitamin D receptor gene polymorphism in hypercalciuric children. Pediatr Nephrol 2004;19:724–727.
26.
Gunes S, Bilen CY, Kara N, Asci R, Bagci H, Yilmaz AF: Vitamin D receptor gene polymorphisms in patients with urolithiasis. Urol Res 2006;34:47–52.
27.
Nishijima S, Sugaya K, Naito A, Makoto M, Hatano T, Ogawa Y: Association of vitamin D receptor gene polymorphism with urolithiasis. J Urol 2002;167:2188–2191.
28.
Liu CC, Huang CH, Wu WJ, Huang SP, Chou IH, Li CC, Chai CY, Wu MT: Association of vitamin D receptor (FokI) polymorphism with the clinical presentation of calcium urolithiasis. BJU Int 2007;99:1534–1538.
29.
Seyhan S, Yavascaoglu I, Kilicarslan H, Dogan HS, Kordan Y: Association of vitamin D receptor gene Taq I polymorphism with recurrent urolithiasis in children. Int J Urol 2007;14:1060–1062.
30.
Jackman SV, Kibel AS, Ovuworie CA, Moore RG, Kavoussi LR, Jarrett TW: Familial calcium stone disease: Taq I polymorphism and the vitamin D receptor. J Endourol 1999;13:313–316.
31.
Mittal RD, Hemant KB, Anant K, Bhandari M: Association of urokinase gene 3′-UTR polymorphism with calcium oxalate nephrolithiasis. J Endourol 2006;20:157–160.
32.
Relan V, Khullar M, Singh SK, Sharma SK: Association of vitamin d receptor genotypes with calcium excretion in nephrolithiatic subjects in northern India. Urol Res 2004;32:236–240.
33.
Yao J, Kathpalia P, Bushinsky DA, Favus MJ: Hyperresponsiveness of vitamin D receptor gene expression to 1,25 dihydroxyvitamin D3. J Clin Invest 1998;91:2223–2232.
34.
Brown EM, MacLeod RJ: Extracellular calcium sensing and extracellular signaling. Physiol Rev 2001;81:239–297.
35.
Yao JJ, Bai S, Karnauskas AJ, Bushinsky DA, Favus MJ: Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 2005;16:1300–1308.
36.
Cole DEC, Peltekova VD, Rubin LA, Hawker GA, Virth R, Hwang DM, Evrovski J, Hendy GN: A986S polymorphism of calcium-sensing receptor and circulating calcium concentrations. Lancet 1999;353:112–115.
37.
Heath H, Oldberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NRM, Krapcho KJ, Hung BC, Capuano IV, Garret JE, Leppert MF: Clustered inactivating mutation and benign polymorphisms of calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 1996;8:1312–1317.
38.
Vezzoli G, Annalisa T, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G, Brandi ML: Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 2002;13:2517–2523.
39.
Corbetta S, Eller-Vainicher C, Filopanti M, Saeli P, Vezzoli G, Arcidiacono T, Loli P, Syren ML, Soldati L, Beck-Peccoz P, Spada A: R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism. Eur J Endocrinol 2006;155:687–692.
40.
Vezzoli G, Terranegra A, Arcidiacono T, Biasion R, Coviello D, Syren ML, Paloschi V, Giannini S, Mignogna G, Rubinacci A, Ferraretto A, Cusi D, Bianchi G, Soldati L: R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int 2007;71:1155–1162.
41.
Scillitani A, Guarnieri V, Battista C, De Geronimo S, Muscarella LA, Chiodini I, Cignarelli M, Minisola S, Bertoldo F, Franucci CM, Malavolta N, Piovesan A, Mascia ML, Muscarella S, Hendy GN, D’Agruma L, Cole DEC: Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. J Clin Endocrinol Metab 2007;92:277–283.
42.
Hamilton DC, Grover VK, Smith CA, Cole DEC: Heterogeneous disease modeling for Hardy-Weinberg disequilibrium in case-control studies: application to renal stones and calcium-sensing receptor polymorphisms. Ann Hum Genetics 2009;73:176–183.
43.
Harding B, Curley AJ, Hannan FM, Christie PT, Bowl MR, Turner JJO, Barbert M, Nasenya IG, Hampson G, Spector TD, Thakker RV: Functional characterization of calcium-sensing receptor polymorphisms and absence of association with indices of calcium homeostasis and bone mineral density. Clin Endocrinol 2006;65:598–605.
44.
Bollerslev J, Wilson SG, Dick IM, Devine A, Dhaliwal SS, Prince RL: Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rates in a large cohort of elderly women. Calcif Tissue Int 2004;74:12–17.
45.
Tsukamoto K, Orimo H, Hosoi T, Miyao M, Ota N, Nakajima T, Yoshida H, Watanabe S, Suzuki T, Emi M: Association of bone mineral density with polymorphism of the human calcium-sensing receptor locus. Calcif Tissue Int 2000;66:181–183.
46.
Lorentzon M, Lorentzon R, Lerner UH, Nordström P: Calcium-sensing receptor gene polymorphism, circulating calcium concentration and bone mineral density in healthy adolescent girls. Eur J Endocrinol 2001;144:257–261.
47.
Takáks I, Speer G, Bajnok E, Tabák A, Nagy Z, Horváth C, Kovács K, Lakatos P: Lack of association between calcium-sensing receptor gene ‘A986S’ polymorphism and bone mineral density in Hungarian postmenopausal women. Bone 2002;30:849–852.
48.
Young R, Wu F, Van de Water N, Ames R, Gamble G, Reid IR: Calcium-sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal women. J Clin Endocrinol Metab 2003;88:697–700.
49.
Pérez-Castrillon JL, Sanz A, Silva J, Justo I, Velasco E, Dueñas A: Calcium-sensing receptor gene A986S polymorphism and bone mass in hypertensive women. Arch Med Res 2006;37:607–611.
50.
Heilberg IP, Boim MA, Schor N: Biochemical differences between stone formers and normal subjects; in Segura J, Conort P, Khoury S, Pak C, Preminger GM, Tolley D (eds): Stone Disease. 1st International Consultation on Stone Disease. Health Publications, Editions 21, Paris, 2003 pp 61–64.
51.
Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N: The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137–1141.
52.
Devuyst O, Pirson Y: Genetics of hypercalciuric stone forming diseases. Kidney Int 2007;72:1065–1072.
53.
Goldfarb DS, Fischer ME, Keich Y, Goldberg J: A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 2005;67:1053–1061.
54.
Tessier J, Petrucci M, Trouvé ML, Valiquette L, Guay G, Ouimet D, Bonnardeaux A: A family-based study of metabolic phenotypes in calcium urolithiasis. Kidney Int 2001;60:1141–1147.
55.
Pak CY, McGuire J, Peterson R, Britton F, Harrod MJ: Familial absorptive hypercalciuria in a large kindred. J Urol 1981;126:717–719.
56.
Coe FL, Parks JH, Moore ES: Familial idiopathic hypercalciuria. N Engl J Med 1979;300:337–340.
57.
Hunter DJ, de Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD: Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci 2002;103:259–265.
58.
Loredo-Osti JC, Roslin NM, Tessier J, Fujiwara TM, Morgan K, Bonnardeaux A: Segregation of urine calcium excretion in families ascertained for nephrolithiasis: evidence for a major gene. Kidney Int 2005;68:966–971.
59.
Heilberg IP, Martini LA, Teixeira SH, Szejnfeld VL, Carvalho AB, Draibe SA, Ajzen H, Ramos OL, Schor N: Bone disease in calcium stone forming patients. Clin Nephrol 1994;42:175–182.
60.
Weisinger JR, Allonzo E, Bellorin-Font E, Blasini AM, Rodriguez MA, Paz-Martínez V, Martinis R: Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 1996;49:244–250.
61.
Misael da Silva AM, dos Reis LM, Pereira RC, Futata E, Branco-Martins CT, Noronha IL, Wajchemberg BL, Jorgetti V: Bone involvement in idiopathic hypercalciuria. Clin Nephrol 2002;57:183–191.
62.
Pérez A, Ulla M, Garcia V, Lavezzo M, Elias E, Binci M, Rivoira M, Centeno V, Alisio A, Talamoni NT. Genotypes and clinical aspects associated with bone mineral density in Argentine post-menopausal women. J Bone Miner Metab 2008;26:358–365.
63.
Dawson-Hughes B, Harris SS, Finneran S: Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995;80:3657–3661.
64.
Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Chailurkit L, Piaseu N, Teerarungsikul K, Sirisriro R, Komindr S, Puavilai G: Vitamin D receptor gene polymorphism is associated with urinary calcium excretion but not with bone mineral density in postmenopausal women. J Endocrinol Invest 1997;20:592–596.
65.
Chen WC, Chen HY, Hsu CD, Wu JY, Tsai FJ: No association of vitamin D receptor gene BsmI polymorphisms with calcium oxalate stone formation. Mol Urol 2001;5:7–10.
66.
Bid HK, Kumar A, Kapoor R, Mittal R: Association of vitamin D receptor-gene (FokI) polymorphism with calcium oxalate nephrolithiasis. J Endourol 2005;19:111–115.
67.
Cole DE Vieth R, Trang HM, Wong BY, Hendy GN, Rubin LA: Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Mol Genet Metab 2001;72:168–174.
68.
Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D’Agruma L, Bertoldo F, Florio C, Minisola S, Hendy GN, Cole DE: Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor gene. J Clin Endocrinol Metab 2004;89:5634–5638.
69.
Bollerslev J, Wilson SG, Dick IM, Devine A, Dhaliwal SS, Prince RL: Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rates in a large cohort of elderly women. Calc Tissue Int 2004;74:12–17.
70.
Vezzoli G, Soldati L, Arcidiacono T, Terranegra A, Biasion R, Russo CR, Lauretani F, Bandinelli S, Bartali B, Cherubini A, Cusi D, Ferrucci L: Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study. Kidney Int 2005;67:2006–2014.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.